Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.

MLA

Moser, Elizabeth C., et al. “Risk of Second Cancer after Treatment of Aggressive Non-Hodgkin’s Lymphoma; an EORTC Cohort Study.” Haematologica, vol. 91, no. 11, Nov. 2006, pp. 1481–88. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17043014&authtype=sso&custid=ns315887.

APA

Moser, E. C., Noordijk, E. M., van Leeuwen, F. E., Baars, J. W., Thomas, J., Carde, P., Meerwaldt, J. H., van Glabbeke, M., & Kluin-Nelemans, H. C. (2006). Risk of second cancer after treatment of aggressive non-Hodgkin’s lymphoma; an EORTC cohort study. Haematologica, 91(11), 1481–1488.

Chicago

Moser, Elizabeth C, Evert M Noordijk, Flora E van Leeuwen, Joke W Baars, José Thomas, Patrice Carde, Jacobus H Meerwaldt, Martine van Glabbeke, and Hanneke C Kluin-Nelemans. 2006. “Risk of Second Cancer after Treatment of Aggressive Non-Hodgkin’s Lymphoma; an EORTC Cohort Study.” Haematologica 91 (11): 1481–88. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17043014&authtype=sso&custid=ns315887.